Use of measles supplemental immunization activities (SIAs) as a delivery platform for other maternal and child health interventions: Opportunities and challenges

Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system

“…Both perspectives were cited by respondents in our study. Delivering other interventions during the MenA vaccine campaign would have involved important challenges (such as logistical, financial, and communication), as other researchers have also noted 41 – 43 . However, the overall lack of discussion at the level of the Ministry of Health for such activities meant that the campaign remained very vertical.…”

“…However, the overall lack of discussion at the level of the Ministry of Health for such activities meant that the campaign remained very vertical. Other researchers have also noted that there are many missed opportunities for using campaigns to strengthen integrated service delivery 37 , 38 , 41 , 44 …”

Impact of supplemental immunisation activity (SIA) campaigns on health systems: findings from South Africa

“…SIAs can reduce coverage heterogeneity and may be required to achieve equitable access to basic child health services 30–32. SIAs may also be cost-effective,33–35 and can be used as a delivery platform for other maternal and child health interventions 9 36. Finally, SIAs can bring diversified training opportunities and lead to aspirational fulfilment for health workers, when directed to work on the SIA campaigns and serve marginalised populations in remote areas.…”

Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad

“…[18][19][20] If the requirement for a cold chain can be reduced, it may also be possible to use vaccination activities as a better delivery platform for other maternal and child health interventions. 21 Third, the use of a CTC for a relatively thermostable vaccine could free up valuable space in cold storage for other vaccines that have poorer thermostability. 22 For epidemic meningococcal meningitis, prevention by vaccination -at a vaccine cost of approximately US$ 0.50 per dose -appears to yield a much better return on investment than treatment -at a mean cost for the health sector of about US$ 26 per meningitis case managed.…”